Osaic Holdings’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

Osaic Holdings’s Portfolio CYTH Stock Details CYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-67	Closed	-$39	–	7792
2024 Q4	$39	Hold	67	–	–	﹤0.01%	7307
2024 Q3	$52	Hold	67	–	–	﹤0.01%	7296
2024 Q2	$85	Hold	67	–	–	﹤0.01%	7262
2024 Q1	$93	Sell	67 -533	-89%	-$881	﹤0.01%	7044
2023 Q4	$954	Hold	600	–	–	﹤0.01%	6770
2023 Q3	$852	Sell	600 -4,000	-87%	-$6.15K	﹤0.01%	6869
2023 Q2	$7.31K	Buy	4,600 +4,000	+667%	+$5.11K	﹤0.01%	6130
2023 Q1	$504	Hold	600	–	–	﹤0.01%	7129
2022 Q4	$1K	Hold	600	–	–	﹤0.01%	7003
2022 Q3	$1K	Buy	+600	New	+$1.26K	﹤0.01%	7111
2022 Q1	–	Sell	-900	Closed	-$3K	–	7562
2021 Q4	$3K	Buy	+900	New	+$5.1K	﹤0.01%	6929

Osaic Holdings's CYTH Position: Q1 2025 in Review

Osaic Holdings sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q1 2025, closing a stake of 67 shares — an estimated $39 sold.

Osaic Holdings first reported a position in CYTH in Q4 2021 and held it in 11 quarters. The position peaked at $7.31K in Q2 2023. 0 funds tracked by Wall St. Rank hold CYTH as of Q1 2025.

Osaic Holdings reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Osaic Holdings sold 67 Cyclo Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $39.
Osaic Holdings first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Osaic Holdings's Cyclo Therapeutics, Inc. Common Stock position peaked at $7.31K in Q2 2023.
0 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.